BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37664054)

  • 1. Targeted panel sequencing in the routine diagnosis of mature T- and NK-cell lymphomas: report of 128 cases from two German reference centers.
    Böck J; Maurus K; Gerhard-Hartmann E; Brändlein S; Kurz KS; Ott G; Anagnostopoulos I; Rosenwald A; Zamò A
    Front Oncol; 2023; 13():1231601. PubMed ID: 37664054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas.
    Breinholt MF; Schejbel L; Gang AO; Nielsen TH; Pedersen LM; Høgdall E; Nørgaard P
    Eur J Haematol; 2023 Oct; 111(4):583-591. PubMed ID: 37452559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
    Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
    Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
    Huang HS; Liao CK; Liu TT; You HL; Wang MC; Huang WT
    Hum Pathol; 2018 Oct; 80():145-151. PubMed ID: 29885407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput detection of clinically targetable alterations using next-generation sequencing.
    Vendrell JA; Grand D; Rouquette I; Costes V; Icher S; Selves J; Larrieux M; Barbe A; Brousset P; Solassol J
    Oncotarget; 2017 Jun; 8(25):40345-40358. PubMed ID: 28404952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms.
    Vega F; Amador C; Chadburn A; Feldman AL; Hsi ED; Wang W; Medeiros LJ
    Ann Diagn Pathol; 2020 Dec; 49():151623. PubMed ID: 32947231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia.
    Madsen MB; Kiss K; Cilius Nielsen F; Bennedbæk FN; Rossing M
    Front Endocrinol (Lausanne); 2020; 11():146. PubMed ID: 32265839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.
    Norton AJ; Isaacson PG
    Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.
    Cho J; Yoon SE; Kim SJ; Ko YH; Kim WS
    BMC Cancer; 2021 Aug; 21(1):972. PubMed ID: 34461835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders.
    Jajosky AN; Havens NP; Sadri N; Oduro KA; Moore EM; Beck RC; Meyerson HJ
    Am J Clin Pathol; 2021 Aug; 156(3):433-444. PubMed ID: 33712839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Zugazagoitia J; Rueda D; Carrizo N; Enguita AB; Gómez-Sánchez D; Díaz-Serrano A; Jiménez E; Mérida A; Calero R; Lujan R; De Miguel E; Gámez P; Díaz-Hellín V; Nuñez JA; Iglesias L; Ferrer I; Paz-Ares L; Ponce-Aix S
    Clin Lung Cancer; 2018 Jan; 19(1):65-73.e7. PubMed ID: 28780976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision diagnostics in lymphomas - Recent developments and future directions.
    Mansouri L; Thorvaldsdottir B; Laidou S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2022 Sep; 84():170-183. PubMed ID: 34699973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aggressive B‑cell lymphomas : Recommendations from the German Panel of Reference Pathologists in the Competence Network on Malignant Lymphomas on diagnostic procedures according to the current WHO classification, update 2017].
    Klapper W; Fend F; Feller A; Hansmann ML; Möller P; Stein H; Rosenwald A; Ott G
    Pathologe; 2019 Mar; 40(2):152-156. PubMed ID: 29666909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.